Data on Chronic Obstructive Pulmonary Disease Detailed by a Researcher at Kumamoto University (T3 Intratracheal Therapy Alleviates Pulmonary Pathology in an Elastase-Induced Emphysema-Dominant COPD Mouse Model).

Předmět:	CHRONIC obstructive pulmonary disease LABORATORY mice RESEARCH personnel ANIMAL disease models PATHOLOGY
Zdroj:	Respiratory Therapeutics Week; 1/12/2024, p224-224, 1p
Abstrakt:	A recent report from Kumamoto University in Japan discusses the potential therapeutic role of thyroid hormone (T3) in treating chronic obstructive pulmonary disease (COPD). The study used mouse models to explore the effects of T3 treatment on different types of COPD. The researchers found that intratracheal T3 treatment resulted in significant improvements in emphysema and respiratory function in the elastase-induced COPD model. However, T3 treatments did not improve COPD pathology in another type of mouse model. The study suggests that T3 supplementation may have therapeutic potential for acute COPD exacerbation but not chronic COPD. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu